Posts Tagged ‘ Avaulta ’

C.R. Bard May Settle 500 Cases for $21 Million

Oct 8th, 2014 | By
C.R. Bard May Settle 500 Cases for $21 Million

October 8, 2014 – Readers of Mesh News Desk have been wondering why there has been no news on the C.R. Bard front while other mesh manufacturers are quietly settling pelvic mesh-injury cases. Bloomberg reports an agreement has been reached between lawyers and C.R. Bard to resolve more than 500 product liability lawsuits with a
[continue reading...]



MND Interviews Dr. Veronikis: On Transvaginal Mesh, Injuries and Explants

Dec 19th, 2013 | By
MND Interviews Dr. Veronikis: On Transvaginal Mesh, Injuries and Explants

The name of Dr. Dionysios Veronikis St. Louis is one that is increasingly heard among mesh-injured women.  Dr. Veronikis tells Mesh News Desk (MND) he now spends half of his time doing mesh removal surgeries, also known as explants, and although he still uses synthetic mesh on rare occasions, his surgical skills allow him to
[continue reading...]



Law Professor Thomas A. Eaton on Tort Reform

Aug 29th, 2013 | By
Law Professor Thomas A. Eaton on Tort Reform

Earlier this month, the jury in the federal Donna Cisson transvaginal mesh case awarded Mrs. Cisson $1.75 million in punitive damages in addition to the $250,000 in compensatory damages. The Cisson case established the Bard Avaulta mesh she received as a treatment for pelvic organ prolapse was defective. Yet readers learned something startling about any
[continue reading...]



75% of Cisson Punitive Damages Goes to Georgia

Aug 16th, 2013 | By
75% of Cisson Punitive Damages Goes to Georgia

One day after the Donna Cisson case comes word that 75 percent of her $1.75 million punitive award will go to the state of Georigia’s general fund. It is the result of the tort reform movement that has quietly crept into U.S. courts around the country, capping jury verdicts and making court a less tempting
[continue reading...]



C.R. Bard Transvaginal Mesh Case Week 2 – Bard Avaulta Never Studied in Humans

Aug 6th, 2013 | By
C.R. Bard Transvaginal Mesh Case Week 2 – Bard Avaulta Never Studied in Humans

As the trial of Donna Cisson v. C.R. Bard moves into its second week, Mesh Medical Device News Desk (MDND) is exploring the documents filed in the case so far. MDND readers can help dig deeper by reading the multi-page depositions which appears throughout the story. The Donna Cisson trial began July 29 after a
[continue reading...]



September Mesh News

Aug 1st, 2013 | By
September Mesh News

Welcome to Mesh Medical Device News Desk (MDND) where you can keep up with what is currently going on regarding transvaginal, incontinence and hernia mesh and the medical news and litigation surrounding it. First and foremost if you are not aware – two years ago July the FDA issued a warning that transvaginal mesh is
[continue reading...]



Readers Resource on Upcoming WV Transvaginal Mesh Cases

Jul 15th, 2013 | By
Readers Resource on Upcoming WV Transvaginal Mesh Cases

Here is the schedule for the upcoming cases filed in Charleston, WV, 26,769 as of last week. Remember there are four cases naming C.R. Bard that will be heard back to back. These are bellwether cases that could signal a settlement if the product liability cases are successful. As of last week there were 26,769
[continue reading...]



Bard Opening Arguments in Federal Transvaginal Mesh Case

Jul 9th, 2013 | By
Bard Opening Arguments in Federal Transvaginal Mesh Case

July 9, 2013 ~“Our job together is to figure out the facts. Trust is a sacred and powerful thing. Although a corporation may be doing good work, if you find they failed in warning, making and manufacturing this device, you must hold them accountable.” That was the opening statement from attorney Henry Garrard who represents
[continue reading...]



C.R. Bard Transvaginal Mesh Case Begins in Federal Court in West Virginia

Jul 7th, 2013 | By
C.R. Bard Transvaginal Mesh Case Begins in Federal Court in West Virginia

July 7, 2013~ The Donna Cisson bellwether case is set for jury selection and opening arguments July 8th in a Charleston, West Virginia federal courthouse. Defendant C.R. Bard is named along with Bard Urological, a division of C.R. Bard, Inc. that designed, manufactured, marketed, packaged, labeled and sold the product in question – the Avaulta
[continue reading...]



Happy Anniversary Food and Drug Administration – Now What?

Jul 2nd, 2013 | By
Happy Anniversary Food and Drug Administration – Now What?

July 2, 2013 ~ Many of you may be aware that the entire pursuit of lawsuits against mesh manufacturers began two years ago this month with the issuance of a safety warning from the U.S. Food and Drug Administration concerning transvaginal mesh. FDA Safety Communication: UPDATE on Serious Complications Associated with Transvaginal Placement of Surgical
[continue reading...]



We hope you find this a helpful resource. National News Editor, Jane Akre, began MDND with the hope of providing the latest news, information and perspective from the regulatory, industry and patient point of view, something that goes under-reported in much of the coverage of medical devices. The public is just now becoming aware that many devices do not undergo the same scrutiny as prescription drugs and are instead grandfathered in under an FDA loophole that has gone largely unchanged since the 1970s. As a result, patients become the post-market clinical trial subjects, and many suffer devastating and permanent injuries.